ZLAB 26.72 (+1.91%)
US98887Q1040BiotechnologyBiotechnology

Zai Lab (ZLAB) Stock Highlights

26.72 | +1.91%
2024-12-21 02:58:44
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatment across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC. The other product candidate includes Fugan, ZL-2302, and ZL-1101.

Statistics

Range Today
25.96 27.33
Volume Today 392.2K
Range 1 Year
13.48 36.6
Volume 1 Year 181.2M
Range 3 Year
13.48 73.85
Volume 3 Year 490.68M
Range 10 Year
13.48 193.54
Volume 10 Year 825.86M

Highlights

Market Capitalization 3.15B (mid)
Floating Shares 882.53M
Current Price 26.72
Price To Earnings -9.78
Price To Revenue 91.43
Price To Book 4.27
Earnings Per Share -3.07
Payout Ratio 0%

Performance

Latest +1.91%
1 Month +0.49%
3 Months +26.82%
6 Months +48.36%
1 Year -8.77%
3 Years -63.55%
5 Years -32.68%
10 Years +10.19%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.